Application of continuous monitoring of parathyroid hormone during parathyroidectomy in patients with secondary hyperparathyroidism

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031119

Enrollment

Unknown

Registered

2020-03-22

Start date

2020-04-28

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with secondary hyperparathyroidism

Interventions

single arm:Parathyroidectomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with secondary hyperparathyroidism due to uremia requiring parathyroidectomy.

Exclusion criteria

Exclusion criteria: With contraindications for parathyroidectomy.

Design outcomes

Primary

Measure	Time frame
Parathyroid hormone;	—

Countries

China

Contacts

Public ContactYan Sun

The Third Affiliated Hospital of Chongqing Medical University

gsunyan@163.com+86 13983819430

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026